Menstrual Cycle Markers of Ovarian Aging and Sex Steroid Hormone Genotypes

2006 ◽  
Vol 119 (9) ◽  
pp. S31-S43 ◽  
Author(s):  
MaryFran R. Sowers ◽  
Mary L. Jannausch ◽  
Daniel S. McConnell ◽  
Sharon R. Kardia ◽  
John F. Randolph
2016 ◽  
Vol 219 (2) ◽  
pp. 486-493 ◽  
Author(s):  
L. Ekenros ◽  
Z. Papoutsi ◽  
C. Fridén ◽  
K. Dahlman Wright ◽  
A. Lindén Hirschberg

2018 ◽  
Vol 46 (3) ◽  
pp. 283-289 ◽  
Author(s):  
Yoshikazu Taketa ◽  
Kanta Horie ◽  
Tetsuya Goto ◽  
Etsuko Ohta ◽  
Kyoko Nakano-Ito ◽  
...  

Mifepristone, which is an orally active synthetic steroid with antiprogesterone activity, is known as an ovarian toxicant. Because the available data regarding the histopathologic characteristics of ovarian toxicity in nonhuman primates are limited, the present study was undertaken in order to investigate detailed histopathologic changes accompanying mifepristone-induced ovarian toxicity and its relationship to changes in menstrual cycle and circulating sex steroid hormone. Twenty mg/kg of mifepristone was orally administered daily to 4 cynomolgus monkeys for 2 months. Mifepristone inhibited the cyclic increases in circulating estradiol-17β and progesterone levels with associated absence of menstruation. Histopathologically, the ovary in the treated animals showed follicular phase without changes in the percentage of atretic antral follicles, and reduced endometrial thickness was noted in the uterus. These changes indicated that a certain degree of antral follicle development had been retained in spite of the menstrual cycle having been arrested in mifepristone-treated animals. Our investigation suggested that it is important to perform detailed histopathologic examination of reproductive organs with precise knowledge of the characteristics of each menstrual stage to detect ovarian toxicity in nonhuman primates. Monitoring menstrual signs and circulating sex steroid hormone levels provides additional evidence for the investigation of the mechanism of ovarian toxicity.


2007 ◽  
Vol 86 (11) ◽  
pp. 1377-1384 ◽  
Author(s):  
Marie Westergren Söderberg ◽  
Bengt Johansson ◽  
Britt Masironi ◽  
Birgitta Byström ◽  
Christian Falconer ◽  
...  

2002 ◽  
Vol 14 (4) ◽  
pp. 241 ◽  
Author(s):  
Hilde Vermeirsch ◽  
Wim Van Den Broeck ◽  
Mark Coryn ◽  
Paul Simoens

The aim of this immunohistochemical study was to describe the cellular distribution of the estrogen receptor-α (ERα), progesterone receptor (PR) and androgen receptor (AR) in canine uterine tubes. Samples of uterine tubes were taken from dogs in different stages of the estrous cycle, and dogs that were pregnant or had just delivered. Nuclear staining for sex steroid hormone receptors was observed in the surface epithelium, stromal cells and smooth muscle cells of the muscular layer. Only slight differences in staining pattern were observed between the ampulla and fimbriae. The staining for ERα and PR showed changes throughout the estrous cycle. Some of these changes were related to changing concentrations of sex steroid hormones. High staining scores for ERα and PR were found during proestrus and low scores during early metestrus. The staining for AR showed only minor cyclic changes. However, during proestrus and estrus, cytoplasmic staining for AR was observed in differentiated secretory epithelial cells, when nuclear staining in these cells was nearly absent. For the three hormone receptors, stromal cells generally stained with a higher intensity than epithelial cells. It is likely that many steroid hormone actions on the epithelium are mediated through stromal cells. During pregnancy, rather high staining scores were found for ERα and AR in the uterine tube. This is in contrast to observations in the canine pregnant uterus.


Sign in / Sign up

Export Citation Format

Share Document